Introduction
Visual evoked potentials (VEPs) are visually evoked electrophysiological signals extracted from electroencephalographic activity in the visual cortex, recorded on the scalp1. Giant evoked potentials (poly(ethylene glycol) [PEGs]) are cortical evoked potentials that were initially described by Dawson in 1947 in patients with sensory stimulus reflex myoclonus2,3. They have also been described in many other disorders, primarily related to cortical myoclonus associated with progressive myoclonic epilepsy, idiopathic epilepsy, as well as toxic, metabolic, and infectious myoclonus. However, its clinical significance is not clearly defined, and its presence does not necessarily imply a pathology of the central nervous system (CNS)2-5.
The amplitude of an evoked component can be measured from the baseline to the maximum peak or from the peak of one component to the peak of the next component with inverted polarity6. Multiple nosological entities have a common factor: the genesis of cortical evoked responses of great amplitude. These have been commonly called giant evoked potentials (PEG). In most cases, these are conditions that have the common clinical characteristic of the presence of myoclonus of cortical origin, such as progressive myoclonic epilepsy7 and myoclonus of toxic origin8.
VEPs are of particular clinical utility in determining a physiological abnormality where neurological and ophthalmological examinations are normal. VEPs are extremely sensitive and can detect a non-discernible dysfunction at the level of a neurological, ophthalmological examination, or another type of revision. The primary measurement of clinical interest is the latency of P100 after stimulus application. The abnormality is particularly clear if the P100 is normal after stimulation of the other eye, more posterior and chiasmatic lesions or a generalized cerebral dysfunction can cause a bilateral prolongation of the P100, usually with similar prolongation when testing each eye separately9.
Methods
At the Centro Médico Nacional (CMN) 20 de Noviembre, a descriptive, observational, and cross-sectional analysis of patients was performed at the Clinical Neurophysiology Service, which found giant VEPs in the period from 2012 to 2018. The information obtained was from the clinical file of the patients that met the selection criteria of the population to study. The inclusion criteria were: patients of all ages, patients with identification of giant VEPs in at least two replicas for each side studied, and that they had a complete record with all the variables to study (age, gender, latency, and amplitude of the VEPs, signs, and symptoms on the occasion of shipment, the time elapsed from the beginning of the symptomatology to the realization of the VEPs, diagnoses at the time of the study of the VEPs, the pharmacological treatment used at the time of the study). VEPs were defined as (N75-P100) > 18 μV. The exclusion criteria were patients who did not strictly comply with the definition of giant evoked potentials and in whom there is not a minimum of two replicas with giant evoked potentials on each side studied. The elimination criterion was that there was incomplete information in the clinical file.
In the descriptive analysis, central tendency and dispersion measurement were handled, as well as proportions. For the statistical analysis, the IBM SPSS version 22.0 for Windows program was used. The resulting variables will be compared using the Students t-test when they are measured in ratio scale and with Fishers square or exact test when they are variables in the nominal scale. A significant difference will be taken when a p < 0.05 is obtained.
Results
A descriptive analysis was carried out at the CMN 20 de Noviembre in Mexico City. The study included patients of any age, who had their VEP in at least two replicas for each side, and who had a complete record in the service with all of the variables to be studied at the Neurophysiology Service Clinic from 2012 to 2018. The data collected were age (in months), sex, referral service, shipping diagnosis, pharmacological treatment, values obtained of amplitude (right and left), and latency (right and left).
A total sample of 36 patients was collected. The average age was 25.61 months (standard deviation 25.27 months, minimum 1 month, and maximum 96 months), of which 50% (n = 18) of the sample corresponds to the male gender and 50% (n = 18) to female gender. The most frequent comorbidity of the patients was prematurity, observed in 63.9% (n = 23). No statistically significant difference was observed in the distribution of findings found in the different amplitudes and latencies concerning the patients age (Table 1). However, a statistically significant difference was found in the variable of right and left amplitude with respect to gender (Table 2).
Interpretation | N | Age (months) | p | |
---|---|---|---|---|
Right amplitude | Normal | 14 | 29.64 | 0.52 |
Incremented | 22 | 24.05 | 0.55 | |
Left amplitude | Normal | 9 | 23 | 0.66 |
Incremented | 27 | 27.3 | 0.65 | |
Right latency | Normal | 23 | 29.22 | 0.34 |
Prolonged | 13 | 20.92 | 0.25 | |
Left latency | Normal | 24 | 28.71 | 0.40 |
Prolonged | 12 | 21.25 | 0.30 |
Interpretación | Male (%) | Female (%) | p | |
---|---|---|---|---|
Right amplitude | Normal | 11 (61.1) | 3 (16.7) | 0.008 |
Incremented | 7 (38.9) | 15 (83.3) | ||
Left amplitude | Normal | 1 (5.6) | 8 (44.4) | 0.009 |
Incremented | 17 (94.4) | 10 (55.6) | ||
Right latency | Normal | 13 (72.2) | 10 (55.6) | 0.24 |
Prolonged | 5 (27.8) | 8 (44.4) | ||
Left latency | Normal | 13 (72.2) | 11 (61.1) | 0.36 |
Prolonged | 5 (27.8) | 7 (38.9) |
To improve and standardize information management, the population was divided into six categories according to the age group to which they belonged (Table 3). Analysis of variance was performed according to the age groups previously described to find the mean and standard deviation of the variables of amplitude (right and left) and latency (right and left). In the group of children up to 6 months old, a mean value in the right amplitude of 16.44 uV (standard deviation of 5.25 uV, minimum 10uV, and maximum 22uV) was found. In patients from 7 to 12 months old, the average value found was of 21.23 uV (standard deviation 14.87, minimum 6uV, and maximum 56 uV). In the group of patients from 13 to 18 months old, an average of 26.70 uV was found (standard deviation of 8.43, minimum 20 uV, and maximum 38 uV). Patients from 19 to 24 months of age had a mean of 26.97 uV (standard deviation of 8.88 uV, minimum 20 uV, and maximum 37 uV). In patients with ages 25-48 months, mean right amplitude of 16.78 uV was found (standard deviation 9.21 uV, minimum 4 uV, and maximum 26 uV), and in the group over 49 months old, an average of 16.49 uV was found (standard deviation 11.50 uV, minimum 7, and maximum 23); taking into account all the data obtained, an average of 20.51 uV (standard deviation 11.5, minimum 4, and maximum 56), and a p = 0.609 of the right amplitude was obtained.
Group | Age (months) | n | Percentage |
---|---|---|---|
1 | Up to 6 | 4 | 11.1 |
2 | 7-12 | 15 | 41.7 |
3 | 13-18 | 4 | 11.1 |
4 | 19-24 | 3 | 8.3 |
5 | 25-48 | 6 | 16.7 |
6 | Above to 49 | 4 | 11.1 |
In the same way, statistical analysis was performed for the values obtained in left amplitude, finding an average measurement in patients up to 6 months of 21.91 uV (standard deviation 17.35 uV, minimum 7 uV, and maximum 46 uV). In the group from 7 to 12 months, an average of 22.85 uV was found (standard deviation 9.19 uV, minimum 7 uV, and maximum 42 uV). In 13-18 months patients, an average of 16.23 uV was obtained (standard deviation 12.29 uV, minimum 2uV, and maximum 31 uV). In patients aged 19-24 months, they had a mean of 24.37 uV (standard deviation 8.33 uV, minimum 17 uV, and maximum 33 uV). In patients from 25 to 48 months, a mean of 23.25 uV was found (standard deviation of 2.37 uV, minimum 20 uV, and maximum 27 uV), and in patients older than 49 months, an average of 20.05 uV was found (standard deviation 5.47 uV, minimum 13 uV, and maximum 27 uV); the average of the 36 values evaluated for the left amplitude was 21.89 uV (standard deviation of 9.32 uV, minimum 2 uV, and maximum 46 uV) and a p = 0.847. For the right latency, in the group of patients up to 6 months of age, an average of 136 ms was obtained (standard deviation 30 ms, min 120 ms, and maximum 181 ms). In the group of patients from 7 to 12 months, an average of 155 ms was reported (standard deviation of 41.8 ms, minimum 108 ms, and maximum 258 ms). In patients from 13 to 18 months, an average of 143.5 ms was obtained (standard deviation 28.9 ms, minimum 110 ms, and maximum 177 ms). The average found in patients aged 19-24 months was 133.67 ms (standard deviation of 25.0 ms, minimum 105 ms, and maximum 151 ms), in patients aged from 25 to 48 months, they had an average of 134.67 ms (standard deviation of 32.5 ms, minimum 107 ms, and maximum 194 ms), and in the group of patients older than 49 months there was an average of 117 ms (standard deviation of 11.74 ms, minimum 102 ms, maximum 129). For the right latency, a global average of 142.36 ms was obtained (standard deviation of 34,859 ms, min 102 ms, and max 258 ms) with a p = 0.460. Statistical analysis was also performed to assess left latency by groups and overall, in patients younger than 6 months. They obtained an average of 139.25 ms (standard deviation of 25.35 ms, minimum 119 ms, and maximum 176 ms). In the group of patients 7-12 months, an average of 149.2 ms was observed (standard deviation of 33.9 ms, minimum 106 ms, and max 200 ms). The average found in patients aged 13-18 months was 137.25 ms (standard deviation 25.6, minimum 115 ms, and maximum 174 ms). In the group of patients from 19 to 24 months, an average of 139.67 ms was found (standard deviation 27.46 ms, minimum 108 ms, and maximum 157 ms). In patients from 25 to 48 months, an average was determined of 137.17 ms (standard deviation 34.8 ms, minimum 102 ms, and maximum 198 ms), and in patients older than 49 months, an average of 114.25ms (standard deviation 7.1 ms, minimum 106 ms, and maximum 123 ms); the global left latency values had an average of 140.08 ms (standard deviation of 30.1 ms, range 102-200 ms), and a p = 0.51 was obtained. A compilation of the previous data can be seen in table 4.
Up to 6 months | 7-12 months | 13-18 months | 19-24 months | 25-48 months | Above 49 months | p | |
---|---|---|---|---|---|---|---|
Right amplitude (uV) | 16.44 | 21.23 | 26.70 | 26.97 | 16.78 | 16.49 | 0.60 |
Left amplitude (uV) | 21.91 | 22.85 | 16.23 | 24.37 | 23.25 | 20.05 | 0.84 |
Right latency (mseg) | 136 | 155.33 | 143.5 | 133.67 | 134.67 | 142.36 | 0.46 |
Left latency (mseg) | 139.25 | 149.20 | 137.25 | 139.67 | 137.17 | 140.08 | 0.51 |
Right amplitude data were matched with right latency and used Fishers exact test getting a p = 0.62 and a correlation of 16.7%; in the same way, it was performed with data of left amplitude and left latency obtaining a p = 0.626 and a correlation of 17.1%. Dispersion data graph was made comparing the distribution of means by age groups of right amplitude and right latency, as well as left amplitude and left latency; observing in both graphs that at greater latency there is a less amplitude (Figures 1 and 2).
Discussion
Visual function is considered one of the most important perceptions for development. During motor development, vision provides crucial feedback to the vestibular and proprioceptive systems. The vision allows the development of integrative functions such as hand-eye coordination, visual-manual-oral coordination, learning and object recognition, and learning and visual-spatial recognition.
VEPs are averaged cortical potentials that assess the integrity of the visual pathway. They are easily detectable in premature infants and show a different pattern of maturation. They have shown that they can predict adverse prognoses in infants with generalized CNS conditions, particularly hypoxic-ischemic encephalopathies.
The giant evoked potentials are evoked potentials that were first described by Dawson in 1947 in patients with myoclonus reflex to the sensory stimulus. They have also been described in other disorders, primarily related to cortical myoclonus associated with progressive myoclonic epilepsies (e.g., neuronal ceroid lipofuscinosis, Lafora disease, and mitochondrial cytopathies), generalized idiopathic epilepsies, post-anoxic, toxic, and infectious myoclonus3.
In the present study, which was carried out at the CMN 20 de Noviembre of the Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, after analyzing the information collected in the period from 2012 to 2018 of the patients who met the inclusion criteria, a total sample of 36 patients was collected. The average age was 25.61 months, of which 50% of the sample corresponds to the male gender and 50% to the female gender. The most frequent comorbidity of the patients was prematurity, observed in 63.9% (n = 23)3.
At the time of correlating the variables found, it was generally found that the greater the latency, the lower the amplitude, and a statistically significant difference was found in the variable of right and left amplitude with respect to gender. That is that the amplitude for the right side was significantly increased in female patients compared to male patients, while the amplitude for the left side was significantly increased in male patients compared to female patients. The above, together with the fact that the total sample corresponds to the same proportion of patients concerning gender, give greater validity to the finding, which could indicate a certain correlation of predominance of the side affected depending on gender. This could probably be related to the physiological and structural differences between genders. This finding has not been documented in the published literature. On the other hand, only 1 patient (2.7%) of the total sample had the diagnosis of epilepsy (West Syndrome) in which an increase in the amplitudes of the VEP for both sides was found, which is related to the possible presence of cortical hyperexcitability described in the reference literature3,10.
Another aspect that must be taken into consideration is the finding that most of the patients with giant VEPs were premature (63.9% of the total sample). This was a precedent and the reason for being sent. Such findings had not been previously reported in the literature and one of the hypotheses could be the fact that in the 1st year of life, there are lower impedances specific to the characteristics of the tissues at those ages such as the dimensions (thickness of skin and bone).
It must be admitted that the present study has multiple limitations due to its design: the number of the sample and the quantity of factors studied. However, it is important to add that this could be considered a pivotal study that can establish the basis for studies of greater statistical value such as prospective studies of control cases among others. Furthermore, due to the small sample, it was not possible to perform significant correlations between various factors. In such case, considering increasing the sample and including more factors such as metabolic, hemodynamic, and anthropometric measurements, results with greater statistical significance can be obtained.
Another possibility of study that can be considered based on the present and considering the theory of cortical hyperexcitability could be the performance of electroencephalograms in patients with giant VEPs and their correlation.
At present, no study in the published literature meets the characteristics of the present study, so in the present work, we tried to provide support for another possible utility for the evoked visual potentials. It was demonstrated by a statistical analysis that related factors exist with statistical significance, and this establishes the basis for further study on the subject.
Conclusion
It was generally verified that the greater the latency, there is less amplitude, and a statistically significant difference was found in the variable of right and left amplitude with respect to gender. That is that the amplitude for the right side was significantly increased in female patients compared to male patients, while the amplitude for the left side was significantly increased in male patients compared to female patients. Furthermore, most of the patients with giant VEPs were premature; this has not been reported before. A possible explanation is because, in the 1st years of life, there are lower impedances specific to the characteristics of the tissues at those ages.
No significant correlation was found between the associations of the rest of the variables.
Ethical disclosures
Protection of human and animal subjects. The authors declare that no experiments were performed on humans or animals for this study.
Confidentiality of data. The authors declare that they have followed the protocols of their work center on the publication of patient data.
Right to privacy and informed consent. The authors declare that no patient data appear in this article.